Alterola Biotech, Inc. (ABTI) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 Birkenhead, 英国. 现任CEO为 David John Hitchcock.
ABTI 拥有 IPO日期为 2010-05-05, 1 名全职员工, 在 Other OTC, 市值为 $7.44M.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
